Pfizer Inc

NEW INFECTIOUS DISEASES INSTITUTE (IDI)
TO ENHANCE TREATMENT OF PATIENTS
AND TRAINING OF HEALTH PROFESSIONALS IN SUB-SAHARAN AFRICA

10-20-2004

The Infectious Diseases Institute (IDI), a new medical facility providing state of the art training and treatment of HIV/AIDS and other infectious diseases opened its doors on the grounds of the Makerere University... more

‘REMARKABLE RESULTS’ MADE IN EFFORT TO ELIMINATE
BLINDING TRACHOMA IN THE DEVELOPING WORLD
Pfizer commits to increase treatments from current eight million to 135 million over next five years, a 15-fold expansion

11-11-2003

Pfizer commits to increase treatments from current eight million to 135 million over next five years, a 15-fold expansion... more

PFIZER SHARE CARD REPORT TO AMERICA IDENTIFIES KEY FEATURES
OF A MEANINGFUL PRESCRIPTION DRUG BENEFIT
FOR LOW-INCOME MEDICARE RECIPIENTS

06-16-2003

Pfizer Inc today unveiled a major study that shows overwhelming satisfaction with the Pfizer Share Card program and identifies key features of a meaningful benefit for low-income Medicare beneficiaries... more

ACADEMIC ALLIANCE FOR AIDS CARE AND PREVENTION IN AFRICA BREAKS GROUND ON STATE-OF-THE-ART INFECTIOUS DISEASES INSTITUTE FOR HIV/AIDS CARE, TRAINING, RESEARCH AND PREVENTION

02-26-2003

Groundbreaking ceremonies were held today at Makerere University for the construction of the new Infectious Diseases Institute... more

AFRICAN AND WESTERN ALLIANCE TO BUILD FIRST LARGE-SCALE AIDS MEDICAL TRAINING FACILITY IN AFRICA

06-11-2001

A new alliance of African and Western infectious disease experts, the Academic Alliance for AIDS Care and Prevention in Africa, will soon break ground for the first large-scale HIV/AIDS clinic in Africa... more

PFIZER AND CLARK FOUNDATION ANNOUNCE MAJOR CAMPAIGN TO BATTLE BLINDING TRACHOMA

11-10-1998

Pfizer Inc and the Edna McConnell Clark Foundation today announced a $66 million public health program that will work toward eliminating blinding trachoma in five developing countries... more